Merck (NYSE: MRK) Stock Analysis: Price Target Raised on Strong Q3 Earnings
Merck's strong Q3 performance saw adjusted earnings of $2.49 per share and revenue of $18.09 billion, significantly exceeding analyst expectations. Analysts from Cantor Fitzgerald and Guggenheim raised their price targets for Merck (NYSE: MRK) stock, reflecting increased confidence in the…